Alemtuzumab in the treatment of steroid refractory acute graft-versus-host disease

Reviewer: Neha Vapiwala, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 22 de marzo del 2007

Translation for this article does not exist